IDO1 and depressive symptom measurement: This rate-limiting enzyme is part of an inflammatory process thought to be taking part in depression development as this IDO1 mediates activation of pro-inflammatory cytokines and participated in the production of kynurenine and its metabolites in the brain hippocampus area [131].